Gender-Specific Combination HIV Prevention for Youth in High Burden Settings (MP3-Youth)

Sponsor

New York University (Other)

Overall Status

Completed

CT.gov ID

NCT01571128

Collaborator

University of Nairobi (Other), Impact Research & Development Organization (Other)

1,215

Enrollment

Locations

Arms

16.7

Actual Duration (Months)

405

Patients Per Site

24.3

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

MP3 Youth is a pilot study to evaluate the feasibility and acceptability of a gender-specific combination HIV prevention package for youth (aged 15-24) in high burden settings. The study aims to pilot a combination package of gender-specific interventions in western Kenya in a mobile health delivery format using integrated services delivery.

Condition or Disease	Intervention/Treatment	Phase
HIV Adolescent Behavior Gender	Other: Male-Specific Intervention Package Other: Female-Specific Intervention Package Drug: Pre-Exposure Prophylaxis (Females) Behavioral: Cash Transfer Cohort (Females)	N/A

Detailed Description

The MP3-Youth study will provide critical information for design and evaluation of combination HIV prevention intervention packages that are sensitive to gender-specific risks among this most-at-risk population in high-HIV burden African settings. Our team of biobehavioral and clinical scientists, mathematical modelers, and trial design specialists will:

Aim 1: Identify gender (sex)-specific drivers of HIV acquisition risk, including pregnancy among females, for youth in sub-Saharan Africa, and interventions to best address those risks.

Aim 2: Conduct mathematical modeling to select optimal combination intervention package components and to assess potential population-level impact.

Aim 3: In partnership with a highly-productive nongovernmental organization (NGO) that is delivering PEPFAR-funded HIV prevention services, develop and pilot a combination HIV prevention package specific for female and for male youth - 'MP3-Youth' - in Nyanza Province, Kenya.

Aim 4: Design a phase IV study protocol for testing the effectiveness of a gender-specific youth HIV prevention package in sub-Saharan Africa. We will disseminate these research protocol recommendations, and study instruments including the mathematical modeling tool, as a combination prevention intervention research toolkit.

Design: Study activities comprise systematic review and meta-analysis of the HIV prevention literature for youth in sub-Saharan Africa; development of a mathematical modeling tool; and a community-based HIV combination prevention pilot that will take place in western Kenya. These activities will culminate in a testable combination HIV prevention trial protocol for youth, which is the main study deliverable.

Population: Aim 1: Focus groups will be held with male and female youth, parents, teachers, religious and community leaders. Aim 3: Pilot study will include male and female youths (ages 15-24) from Nyanza Province, Kenya.

Deliverables: Study deliverables include selection procedures for a population-specific combination HIV prevention package; measurement instruments, mobile prevention delivery protocols, mathematical modeling tools, and a testable study trial protocol. The entire MP3-Youth Package will be placed on a web site for open access.

Study Design

Study Type:

Interventional

Actual Enrollment :

1215 participants

Allocation:

Non-Randomized

Intervention Model:

Parallel Assignment

Masking:

None (Open Label)

Primary Purpose:

Prevention

Official Title:

Gender-Specific Combination HIV Prevention for Youth in High Burden Settings (MP3-Youth)

Actual Study Start Date :

Nov 1, 2014

Actual Primary Completion Date :

Mar 23, 2016

Actual Study Completion Date :

Mar 23, 2016

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Male-Specific Intervention Package Gender-specific interventions targeted specifically for boys offered in an integrated services delivery modality. Cross-Sectional Arm.	Other: Male-Specific Intervention Package Combination HIV Prevention: Male-Specific Intervention Package at the Mobile Health events and longitudinal follow up of cohorts. Other Names: HIV Counseling and Testing (HTC) Facilitated linkage to care for HIV+: ART/PMTCT Condoms Voluntary Medical Male Circumcision (VMMC)
Experimental: Female-Specific Intervention Package Gender-specific interventions targeted specifically for girls offered in an integrated services delivery modality. Cross-Sectional Arm.	Other: Female-Specific Intervention Package Combination HIV Prevention: Female-Specific Intervention Package at the Mobile Health events and longitudinal follow up of cohorts. Other Names: HIV Counseling and Testing (HTC) Facilitated linkage to care for HIV+: ART/PMTCT Contraception/Family Planning (FP) Pre-exposure Prophylaxis (PrEP) Conditional Cash Transfer (CCT)
No Intervention: HIV Positive Cohort (Males and Females) Behavioral data on HIV positive youth. Longitudinal Arm.
Experimental: Pre-Exposure Prophylaxis (Females) PrEP adherence and feasibility. Longitudinal Arm.	Drug: Pre-Exposure Prophylaxis (Females) Females 18-24 who are out of school. Other Names: Truvada Emtricitabine Tenofovir disoproxil fumarate
Experimental: Cash Transfer Cohort (Females) School attendance, behavioral data, and feasibility. Longitudinal Arm	Behavioral: Cash Transfer Cohort (Females) Cash transfer for females (and their parents) who are aged 15-24 and enrolled in school. Other Names: Behavioral Economics Conditional Cash Transfer

Outcome Measures

Primary Outcome Measures

Intervention Uptake (acceptability) and Coverage (feasibility) [6 months]
Coverage: The proportion of youth in the community who attend each mobile event (estimated from youth population denominator) Enrollment: The number of participants who consent to being enrolled in the study during each mobile event. Uptake: The number of participants who choose one or more components of their tailored combination package (and which components). Intervention Acceptability: Satisfaction with mobile event services

Secondary Outcome Measures

Adherence to medication (HIV+ and PrEP cohort participants only) over 12 months [12 months]
Adherence to once daily Truvada (PrEP) among HIV-uninfected eligible females and patterns of adherence and sexual HIV acquisition risk exposure (PrEP cohort participants only). Measured by self-report, eCAPs, and clinical assessments; monthly for first 6 months and every 3 months for the following 6 months and DBS for analysis of TFV/FTC: TFV-DP/FTC-TP at months 2 and 9. Adherence to ART for positives (HIV+ cohort participants only). Measured by self-report monthly SMS: 0, 3, 6,9,12 months). POC CD4 and baseline viral load by dried blood spot will be measured at mobile event baseline and repeated at 12 months.

Other Outcome Measures

Feasibility of administering cash transfer to keep girls in school [12 months]
Conditional Cash Transfer to reduce HIV risk by staying in school.

Eligibility Criteria

Criteria

Ages Eligible for Study:

15 Years to 24 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

Any male or female between the ages of 15-24.
Able to understand spoken English or Kiswahili or Dholuo.
Willing to give informed consent or if younger than 18 years of age has a parent or guardian willing to provide consent in addition to the minor's assent
Willing to be tested for HIV.
Willing to get participant ID based on biometric finger scan.

Exclusion Criteria:

Any male or female younger than 15 or older than 24.
Unable to understand spoken English, or Kiswahili or Dholuo.
If under 18 and not an emancipated minor, unable to get parental consent.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	New York University	New York	New York	United States	10003
2	Impact Research and Development Organization	Kisumu		Kenya
3	University of Nairobi	Nairobi		Kenya

Sponsors and Collaborators

New York University
University of Nairobi
Impact Research & Development Organization

Investigators

Principal Investigator: Irene Inwani, MD, MPH, Kenyatta National Hospital: University of Nairobi, Kenya
Principal Investigator: Ann Kurth, PhD, CNM, New York University
Study Director: Jasmine Buttolph, MPH, New York University